Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease.
about
Percutaneous biopsy for risk stratification of renal massesIndividualising treatment choices in a crowded treatment algorithmTreatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies.Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.MRI phenotype in renal cancer: is it clinically relevant?Retrospective Analysis of the Efficacy and Safety of Sorafenib in Chinese Patients With Metastatic Renal Cell Carcinoma and Prognostic Factors Related to Overall Survival.Long-term survival following multidisciplinary treatment of metastatic sarcomatoid renal cell carcinoma: a case reportPrognostic value of preoperative inflammatory response biomarkers in patients with sarcomatoid renal cell carcinoma and the establishment of a nomogram.Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.Primary pure spindle cell carcinoma (sarcomatoid carcinoma) of the ovary: A case report with immunohistochemical studyA phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma.Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents.Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma.Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid FeaturesProgrammed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.Successful mammalian target of rapamycin inhibitor maintenance therapy following induction chemotherapy with gemcitabine and doxorubicin for metastatic sarcomatoid renal cell carcinoma.Unusual early-stage pancreatic sarcomatoid carcinoma.Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report.A novel prognostic model for patients with sarcomatoid renal cell carcinoma.Lingual metastasis as an initial presentation of renal cell carcinoma: a case report.Clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma.Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma.Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components.Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma.Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.Ki-67 index and percentage of sarcomatoid differentiation were two independent prognostic predictors in sarcomatoid renal cell carcinoma
P2860
Q26783525-078F1679-BFF7-4755-B3C8-9C3663E0B2F7Q27023669-C6A45CFD-475B-4EE0-A990-CBC58CDA2120Q34500828-CD548DD0-7B28-4DA2-84A5-964B38F4C8B6Q35640244-93E2C674-F7B8-4A13-A3FD-FEE5FC7DFC30Q35793032-2A1CE6F5-AFCE-4E80-9AA5-D14BDD688E0DQ36153108-04798E93-B550-4E09-B438-FCF85392D99FQ36298619-24994560-4CFE-493A-A7CE-245EEB2F673DQ36755754-C286070F-DED6-475A-B97E-CFE89D5B001CQ37130057-8E00F94C-3C6E-4A50-95C5-4DB67B6DF848Q37154195-E7325BAB-2369-4347-92AD-6614527E8AA8Q37439016-E7F298F7-87C8-4E2E-B5AF-F9AC1CC3974DQ38196855-9220C1DB-D505-440B-817C-233F4890ADC5Q38543085-2468E829-59F2-4122-B3BE-19D9BD2B3368Q38939134-D432DC8A-E6AA-495A-A558-C59D7EEAAE47Q40498385-57FBDAC3-088B-4A7A-94AD-3DE5F098441CQ40740432-CF3CC51D-182D-41E4-BF06-EE494FDD4AA1Q40891676-66C65277-5034-4153-AC88-AF60507209F1Q41873064-059E4D63-00C3-43DF-AE38-667B8E444BF7Q41969809-8C2EAD1B-3AAC-4093-B53D-341479EEC575Q43967321-9729AF1D-5D41-44CE-A58F-6D7DC5CBEDAEQ44631161-7A806C33-1CE7-4B61-9AE2-7D5B9111361CQ44991304-F5FC0F74-21B0-4FDA-98AC-130B4752609DQ45945323-5874F77F-2E13-4B29-AFE4-3DD263EAD259Q46670559-AFF33440-ABB5-47E1-B56D-509E78F05214Q48036216-1D8FB2CA-D7F9-475E-8220-7F9E2D477257Q52776777-D4786D5A-7FAD-473C-9B12-E7EEBD052843Q59135034-F785F0E9-48E5-453D-8C1D-A843657A7840
P2860
Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Sarcomatoid-variant renal cell ...... survival in advanced disease.
@en
type
label
Sarcomatoid-variant renal cell ...... survival in advanced disease.
@en
prefLabel
Sarcomatoid-variant renal cell ...... survival in advanced disease.
@en
P2093
P2860
P1476
Sarcomatoid-variant renal cell ...... d survival in advanced disease
@en
P2093
Ana M Molina
Lawrence H Schwartz
Michael J Trinos
Nicole Ishill
Paul Russo
Satish K Tickoo
Sujata Patil
Victor E Reuter
P2860
P304
P356
10.1097/COC.0B013E3181F47AA4
P577
2011-10-01T00:00:00Z